State of Wisconsin Investment Board
NGNE icon

State of Wisconsin Investment Board’s Neurogene NGNE Stock Holding History

State of Wisconsin Investment Board’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,135
Closed -$526K – 2130
2021
Q1 		$526K Hold
2,135
– – ﹤0.01% 1583
2020
Q4 		$602K Sell
2,135
-265
-11% -$64.8K ﹤0.01% 1473
2020
Q3 		$576K Buy
+2,400
New +$581K ﹤0.01% 1430

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State of Wisconsin Investment Board's NGNE Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of Neurogene (NGNE) in Q2 2021, closing a stake of 2,135 shares — an estimated $526K sold.

State of Wisconsin Investment Board first reported a position in NGNE in Q3 2020 and held it in 3 quarters. The position peaked at $602K in Q4 2020. 82 funds tracked by Wall St. Rank hold NGNE as of Q2 2021.

  • State of Wisconsin Investment Board reported no remaining Neurogene position as of Q2 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 2,135 Neurogene shares in Q2 2021, an estimated $526K.
  • State of Wisconsin Investment Board first reported a position in Neurogene in Q3 2020 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Neurogene position peaked at $602K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Neurogene as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.